Chiral discrimination and enantioselective analysis of drugs: An overview
β Scribed by Emad L. Izake
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 229 KB
- Volume
- 96
- Category
- Article
- ISSN
- 0022-3549
No coin nor oath required. For personal study only.
β¦ Synopsis
Molecular recognition of different enantiomers of a drug has become of increasing importance in the last decade due to the racemic switch strategy adapted by the pharmaceutical industry. Different analytical techniques to carry out enantioselective analysis of chiral compounds have been suggested in the literature. In the following, a brief overview of different techniques used for enantioselective analysis is given. Challenging aspects of these techniques, such as the quality of analytical information received from each technique, advantages, and disadvantages are discussed. Alternatives (enantioselective membranes, amperometric biosensors, molecularly imprinted polymers (MIPs)), capable of meeting the requirements of industrial processes, in terms of productivity, cost-effectiveness, and environmental issues are critically reviewed.
π SIMILAR VOLUMES
Several chiral drugs are produced and administered as pure enantiomers, whereas many others, especially of synthetic origin, are used mainly in the form of racemates. The biological and pharmacological activity of chiral compounds depends on their configuration. The racemic drugs may exhibit quite d
Chiral stationary phases (CSPs) are becoming abundant and extensively used in resolution of drug racemates. The polysaccharide-type CSPs namely the cellulose and amylose derivatives are widely used in the resolution and analysis of racemate drugs by high performance liquid chromagraphy (